Mark Chang

Earth and Planetary SciencesMedicineEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Study protocol: phase II study to evaluate the effect of cetuximab monotherapy after immunotherapy with PD-1 inhibitors in patients with head and neck squamous cell cancer”.

Study protocol: phase II study to evaluate the effect of cetuximab monotherapy after immunotherapy with PD-1 inhibitors in patients with head and neck squamous cell cancer

Therapeutic Advances in Medical Oncology(2024)10.1177/17588359231217959

N/A

0.315DataRank · unranked

5 citations

Chance H. Bloomer, Elena Gavrila, JOHN MASON KALADA, Mark Chang, Rediet R. Gebeyehu +12 more

Exceptional response to cetuximab monotherapy after failure of immunotherapy with a checkpoint inhibitor in a patient with metastatic head and neck squamous cell cancer: case report and review of the literature

Therapeutic Advances in Medical Oncology(2023)10.1177/17588359231193722

N/A

0DataRank · unranked

4 citations

Elena Gavrila, Kimberly Burcher, JOHN MASON KALADA, Mark Chang, Rediet R. Gebeyehu +8 more